EPAM vs PFE · P/E 14, rev $2.81B vs P/E 20, rev $15.03B
EPAM Systems Inc (EPAM) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the EPAM and PFE stock pages for the full models.
Not investment advice.